Production (Stage)
Black Diamond Therapeutics, Inc.
BDTX
$1.99
-$0.06-2.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 152.40M | 98.58M | 112.68M | 122.97M | 115.20M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.28M | 2.60M | 2.86M | 3.78M | 3.61M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 155.68M | 101.18M | 115.54M | 126.75M | 118.81M |
|
|
|||||
| Total Current Assets | 155.68M | 101.18M | 115.54M | 126.75M | 118.81M |
| Net Property, Plant & Equipment | 19.54M | 20.40M | 21.24M | 22.07M | 22.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.03M | 1.07M | 1.12M | 1.16M | 819.00K |
| Total Assets | 176.25M | 122.64M | 137.90M | 149.99M | 142.52M |
|
|
|||||
| Total Accounts Payable | 2.63M | 4.01M | 1.97M | 763.00K | 1.18M |
| Total Accrued Expenses | 10.51M | 13.16M | 15.50M | 14.42M | 12.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.71M | 3.40M | 3.33M | 3.26M | 3.18M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.85M | 20.57M | 20.80M | 18.44M | 16.85M |
|
|
|||||
| Total Current Liabilities | 16.85M | 20.57M | 20.80M | 18.44M | 16.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.88M | 18.78M | 19.67M | 20.53M | 21.36M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 34.73M | 39.36M | 40.47M | 38.97M | 38.22M |
|
|
|||||
| Common Stock & APIC | 572.10M | 570.37M | 568.44M | 566.70M | 540.06M |
| Retained Earnings | -430.57M | -487.11M | -471.12M | -455.57M | -435.66M |
| Treasury Stock & Other | -19.00K | 24.00K | 107.00K | -115.00K | -95.00K |
| Total Common Equity | 141.52M | 83.29M | 97.43M | 111.02M | 104.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 141.52M | 83.29M | 97.43M | 111.02M | 104.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 141.52M | 83.29M | 97.43M | 111.02M | 104.31M |
|
|
|||||